Ercan Önder, Köstü Bülent, Özer Alev, Serin Salih, Bakacak Murat
a Department of Obstetrics and Gynecology , Kahramanmaras Sütçü İmam University Hospital , Kahramanmaras , Turkey and.
b Tatvan County Hospital , Bitlis , Turkey.
J Matern Fetal Neonatal Med. 2016 Sep;29(17):2810-2. doi: 10.3109/14767058.2015.1105950. Epub 2015 Nov 23.
The efficacy and safety were assessed of a misoprostol regimen used alone or in combination with foley catheter for second trimester pregnancy termination.
A retrospective examination was made of the records of patients who underwent pregnancy termination at 14-24 weeks of gestation in our university hospital between January 2011 and June 2014. Records were available for patients 378 who underwent terminations. Group 1 comprised patients with no history of cesarean section. An initial dose of 200 μg misoprostol was administered intravaginally and then until the termination was completed an additional 200 μgr dose was administered sublingually every 4 hours (Group 1: 234 patients). Group 2 comprised patients with a history of cesarean section. An initial dose of 200 μg misoprostol was administered intravaginally and 2 hours later an intracervical foley catheter was inserted (Group 2: 144 patients).
The total misoprostol dosage used was 1160 μg and 560 μg (p< 0.001), intervals from the administration of the first misoprostol tablet until termination were 854.8 and 704.2 minutes (p= 0.03) in Groups 1 and 2, respectively.
The misoprostol + foley catheter combination reduces the total dosage of misoprostol required for termination and shortens the termination interval, thereby increasing patient's comfort. Based on these results, the usage of the misoprostol + foley catheter combination can be recommended especially for patients with a history of caesarian section.
评估单独使用米索前列醇方案或联合使用 Foley 导管用于孕中期终止妊娠的疗效和安全性。
回顾性分析 2011 年 1 月至 2014 年 6 月在我校医院接受妊娠终止的 14 - 24 周妊娠患者的记录。有 378 例患者的记录可供使用。第 1 组包括无剖宫产史的患者。初始剂量 200 μg 米索前列醇经阴道给药,然后每 4 小时舌下追加 200 μg 剂量直至终止妊娠完成(第 1 组:234 例患者)。第 2 组包括有剖宫产史的患者。初始剂量 200 μg 米索前列醇经阴道给药,2 小时后插入宫颈 Foley 导管(第 2 组:144 例患者)。
第 1 组和第 2 组使用的米索前列醇总剂量分别为 1160 μg 和 560 μg(p<0.001),从首次服用米索前列醇片到终止妊娠的间隔时间分别为 854.8 分钟和 704.2 分钟(p = 0.03)。
米索前列醇 + Foley 导管联合使用可减少终止妊娠所需的米索前列醇总剂量并缩短终止妊娠间隔时间,从而提高患者舒适度。基于这些结果,尤其对于有剖宫产史的患者,可推荐使用米索前列醇 + Foley 导管联合方案。